Delta-Fly Pharma Inc
TSE:4598
Delta-Fly Pharma Inc
TSE:4598
Price:
190
JPY
2.7%
Market Closed
Market Cap:
¥2.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Delta-Fly Pharma Inc
TSE:4598
|
JP |
|
C
|
China Kingstone Mining Holdings Ltd
HKEX:1380
|
CN |
Income Statement
Earnings Waterfall
Delta-Fly Pharma Inc
Delta-Fly Pharma Inc
Income Statement
Delta-Fly Pharma Inc
Delta-Fly Pharma Inc
Currency: JPY
| Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
100
N/A
|
100
N/A
|
200
+100%
|
200
N/A
|
300
+50%
|
400
+33%
|
300
-25%
|
300
N/A
|
300
N/A
|
200
-33%
|
200
N/A
|
200
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||||||||||||
| Operating Expenses |
(593)
|
(704)
|
(1 081)
|
(1 392)
|
(1 646)
|
(1 682)
|
(1 483)
|
(1 293)
|
(1 152)
|
(1 304)
|
(1 243)
|
(1 214)
|
(1 261)
|
(1 161)
|
(1 219)
|
(1 355)
|
(1 316)
|
(1 287)
|
(1 298)
|
(1 239)
|
(1 403)
|
(1 626)
|
(1 726)
|
(1 748)
|
(1 708)
|
(1 569)
|
(1 623)
|
(1 649)
|
|
| Selling, General & Administrative |
(216)
|
(238)
|
(253)
|
(256)
|
(248)
|
(252)
|
(261)
|
(273)
|
(285)
|
(330)
|
(321)
|
(318)
|
(321)
|
(295)
|
(297)
|
(303)
|
(304)
|
(287)
|
(288)
|
(281)
|
(285)
|
(296)
|
(281)
|
(277)
|
(270)
|
(263)
|
(270)
|
(271)
|
|
| Research & Development |
(377)
|
(466)
|
(828)
|
(1 136)
|
(1 398)
|
(1 430)
|
(1 222)
|
0
|
(867)
|
(742)
|
(690)
|
(896)
|
(941)
|
(866)
|
(922)
|
(1 052)
|
(1 012)
|
(1 000)
|
(1 009)
|
(958)
|
(1 119)
|
(1 329)
|
(1 445)
|
(1 470)
|
(1 438)
|
(1 306)
|
(1 353)
|
(1 378)
|
|
| Other Operating Expenses |
0
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
(1 020)
|
0
|
(232)
|
(232)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
|
| Operating Income |
(593)
N/A
|
(704)
-19%
|
(1 081)
-54%
|
(1 392)
-29%
|
(1 546)
-11%
|
(1 582)
-2%
|
(1 283)
+19%
|
(1 093)
+15%
|
(852)
+22%
|
(904)
-6%
|
(943)
-4%
|
(914)
+3%
|
(961)
-5%
|
(961)
+0%
|
(1 019)
-6%
|
(1 155)
-13%
|
(1 316)
-14%
|
(1 287)
+2%
|
(1 298)
-1%
|
(1 239)
+5%
|
(1 403)
-13%
|
(1 626)
-16%
|
(1 726)
-6%
|
(1 748)
-1%
|
(1 708)
+2%
|
(1 569)
+8%
|
(1 623)
-3%
|
(1 649)
-2%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||
| Interest Income Expense |
(0)
|
(2)
|
(3)
|
(6)
|
(6)
|
(4)
|
(3)
|
0
|
(3)
|
(3)
|
(3)
|
(4)
|
(1)
|
(5)
|
(10)
|
(7)
|
(6)
|
(6)
|
(1)
|
(3)
|
(6)
|
(4)
|
(1)
|
(4)
|
(1)
|
2
|
(0)
|
2
|
|
| Total Other Income |
(79)
|
(79)
|
(39)
|
(1)
|
(1)
|
(1)
|
0
|
(0)
|
(4)
|
(6)
|
(6)
|
(5)
|
(2)
|
0
|
0
|
(3)
|
(4)
|
(5)
|
(5)
|
(19)
|
(18)
|
(17)
|
(17)
|
(10)
|
(10)
|
(19)
|
(20)
|
(11)
|
|
| Pre-Tax Income |
(671)
N/A
|
(784)
-17%
|
(1 123)
-43%
|
(1 399)
-25%
|
(1 552)
-11%
|
(1 587)
-2%
|
(1 286)
+19%
|
(1 093)
+15%
|
(859)
+21%
|
(912)
-6%
|
(952)
-4%
|
(924)
+3%
|
(964)
-4%
|
(966)
0%
|
(1 029)
-7%
|
(1 165)
-13%
|
(1 326)
-14%
|
(1 298)
+2%
|
(1 304)
0%
|
(1 261)
+3%
|
(1 427)
-13%
|
(1 646)
-15%
|
(1 744)
-6%
|
(1 762)
-1%
|
(1 719)
+2%
|
(1 586)
+8%
|
(1 643)
-4%
|
(1 659)
-1%
|
|
| Net Income | |||||||||||||||||||||||||||||
| Tax Provision |
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
| Income from Continuing Operations |
(674)
|
(787)
|
(1 127)
|
(1 403)
|
(1 556)
|
(1 591)
|
(1 289)
|
(1 096)
|
(863)
|
(916)
|
(955)
|
(927)
|
(967)
|
(969)
|
(1 032)
|
(1 168)
|
(1 329)
|
(1 301)
|
(1 306)
|
(1 263)
|
(1 429)
|
(1 649)
|
(1 746)
|
(1 764)
|
(1 721)
|
(1 588)
|
(1 646)
|
(1 661)
|
|
| Net Income (Common) |
(674)
N/A
|
(787)
-17%
|
(1 127)
-43%
|
(1 403)
-24%
|
(1 556)
-11%
|
(1 591)
-2%
|
(1 289)
+19%
|
(1 096)
+15%
|
(863)
+21%
|
(916)
-6%
|
(955)
-4%
|
(927)
+3%
|
(967)
-4%
|
(969)
0%
|
(1 032)
-7%
|
(1 168)
-13%
|
(1 329)
-14%
|
(1 301)
+2%
|
(1 306)
0%
|
(1 263)
+3%
|
(1 429)
-13%
|
(1 649)
-15%
|
(1 746)
-6%
|
(1 764)
-1%
|
(1 721)
+2%
|
(1 588)
+8%
|
(1 646)
-4%
|
(1 661)
-1%
|
|
| EPS (Diluted) |
-170.16
N/A
|
-180.2
-6%
|
-251.05
-39%
|
-311.36
-24%
|
-348.32
-12%
|
-353.1
-1%
|
-286.21
+19%
|
-243.42
+15%
|
-187.34
+23%
|
-169.29
+10%
|
-176.23
-4%
|
-171.05
+3%
|
-178.58
-4%
|
-178.8
0%
|
-190.5
-7%
|
-210.83
-11%
|
-211.38
0%
|
-199.6
+6%
|
-199.63
0%
|
-168.89
+15%
|
-173.84
-3%
|
-200.36
-15%
|
-212.18
-6%
|
-195.41
+8%
|
-177.2
+9%
|
-153.29
+13%
|
-143.19
+7%
|
-138.89
+3%
|
|
Switch to:
Switch to:
See Also
Discover More
